Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Jones

Showing results (221-230 of 273) with videos related to

Pageof 28
Sort By:
Schizophrenia Research|December 15, 1996
Factor analysis of schizophrenic symptoms using the OPCRIT checklistA G Cardno, L A Jones, K C Murphy, et al.
American Journal of Medical Genetics|February 21, 1997
No evidence for an allelic association between schizophrenia and markers D22S278 and D22S283N M Williams, L A Jones, K C Murphy, et al.
Nature Genetics|August 1, 1995
Expanded CAG repeats in schizophrenia and bipolar disorderM C O'Donovan, C Guy, N Craddock, et al.
Journal of the American College of Cardiology|February 1, 1993
Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humansT R Porter, A D'Sa, C Turner, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]D G Kieback, M F Press, S K McCamant, et al.
Nuclear Medicine and Biology|August 24, 2001
Comparison of animal models for the evaluation of radiolabeled androgensJ B Downer, L A Jones, J A Engelbach, et al.
Anticancer Research|November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)D G Kieback, M F Press, E N Atkinson, et al.
Cancer Research|October 1, 1987
Bioavailability of estradiol as a marker for breast cancer risk assessmentL A Jones, D M Ota, G A Jackson, et al.
Progress in Clinical and Biological Research|January 1, 1989
Breast cancer screening-individualized risk assessment and application of new research technology: non-protein bound estradiol and chromosome analysisG L Jackson, S Pathak, L A Jones, et al.
Human Gene Therapy|August 31, 1999
Expression of chimeric granulocyte-macrophage colony-stimulating factor/interleukin 2 receptors in human cytotoxic T lymphocyte clones results in granulocyte-macrophage colony-stimulating factor-dependent growthL S Evans, P R Witte, A L Feldhaus, et al.
Pageof 28

Showing results (221-230 of 273) with videos related to

Sort By:
Pageof 28
Schizophrenia Research|December 15, 1996
Factor analysis of schizophrenic symptoms using the OPCRIT checklistA G Cardno, L A Jones, K C Murphy, et al.
American Journal of Medical Genetics|February 21, 1997
No evidence for an allelic association between schizophrenia and markers D22S278 and D22S283N M Williams, L A Jones, K C Murphy, et al.
Nature Genetics|August 1, 1995
Expanded CAG repeats in schizophrenia and bipolar disorderM C O'Donovan, C Guy, N Craddock, et al.
Journal of the American College of Cardiology|February 1, 1993
Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humansT R Porter, A D'Sa, C Turner, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]D G Kieback, M F Press, S K McCamant, et al.
Nuclear Medicine and Biology|August 24, 2001
Comparison of animal models for the evaluation of radiolabeled androgensJ B Downer, L A Jones, J A Engelbach, et al.
Anticancer Research|November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)D G Kieback, M F Press, E N Atkinson, et al.
Cancer Research|October 1, 1987
Bioavailability of estradiol as a marker for breast cancer risk assessmentL A Jones, D M Ota, G A Jackson, et al.
Progress in Clinical and Biological Research|January 1, 1989
Breast cancer screening-individualized risk assessment and application of new research technology: non-protein bound estradiol and chromosome analysisG L Jackson, S Pathak, L A Jones, et al.
Human Gene Therapy|August 31, 1999
Expression of chimeric granulocyte-macrophage colony-stimulating factor/interleukin 2 receptors in human cytotoxic T lymphocyte clones results in granulocyte-macrophage colony-stimulating factor-dependent growthL S Evans, P R Witte, A L Feldhaus, et al.
Pageof 28